|1.||D'Erme, Angelo Massimiliano: 1 article (03/2012)|
|2.||Gola, Massimo: 1 article (03/2012)|
|3.||Carlsen, Berit Christina: 1 article (06/2011)|
|4.||Johansen, Jeanne Duus: 1 article (06/2011)|
|5.||Vind-Kezunovic, Dina: 1 article (06/2011)|
|6.||Wulf, Hans Christian: 1 article (11/2010)|
|7.||Philipsen, Peter A: 1 article (11/2010)|
|8.||Lerche, Catharina M: 1 article (11/2010)|
|9.||Poulsen, Thomas: 1 article (11/2010)|
|10.||Inabinet, Robin: 1 article (01/2009)|
|1.||Atopic Dermatitis (Atopic Eczema)
01/01/2009 - "Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis."
01/01/1984 - "It is concluded that Locoid cream is significantly superior to Uniderm cream in the treatment of atopic dermatitis in children."
10/27/1982 - "In a randomised, double-blind clinical trial, the relative efficacy of Locoid scalp lotion and Betnovate scalp application was assessed in the treatment of 30 patients, 15 in each treatment group, suffering from seborrhoeic or atopic dermatitis of the scalp. "
08/01/2002 - "International, multicentre, prospective, randomized double-blind, left-right studies of cipamfylline vs. vehicle and cipamfylline vs. hydrocortisone 17-butyrate in adult patients with stable symmetrical atopic dermatitis on the arms. "
03/01/2002 - "This study was undertaken to compare 0.03% and 0.1% tacrolimus ointment with 0.1% hydrocortisone-17-butyrate ointment, a midpotent to potent topical corticosteroid, in the treatment of adult patients with moderate-to-severe atopic dermatitis. "
07/01/1999 - "[The Locoid treatment of dermatoses in middle-aged and elderly persons]."
01/01/1986 - "It is concluded that the new application form of Locoid, a fatty cream, is a useful and beneficial addition to topical corticosteroid therapy, which will promote patient compliance in a wide range of corticosteroid-responsive skin diseases."
12/01/1978 - "[Comparative testing of diflucortolon-21-valerate creme and hydrocortisone-17-butyrate creme in patients with dermatoses]."
02/01/1984 - "In a double-blind controlled study with 27 indoor patients good results were achieved in the treatment of infected dermatoses by fusidic acid and by the combination of fusidic acid with hydrocortisone-17-butyrate."
05/01/1980 - "[Effect of 17-hydrocortisone butyrate (locoid) in various skin diseases, and its effect on intact skin in the light of electrothermometric experimental studies]."
|3.||Psoriasis (Pustulosis Palmaris et Plantaris)
04/01/2001 - "The efficacy, safety, and tolerability of twice-daily fluticasone propionate (Cutivate) cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, were compared in 125 patients with moderate-to-severe psoriasis in a 4-week, multicenter, double-blind, randomized, active-control study. "
02/01/1996 - "The efficacy and safety of twice-daily topical application of fluticasone propionate ointment, 0.005%, and hydrocortisone-17-butyrate ointment, 0.1%, were compared in 113 adult patients with moderate-to-severe psoriasis in a multicenter, double-blind, randomized, parallel study. "
04/01/2001 - "A randomized, double-blind, multicenter trial comparing fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, applied twice daily for 4 weeks in the treatment of psoriasis."
02/01/1996 - "A comparison of fluticasone propionate ointment, 0.005%, and hydrocortisone-17-butyrate ointment, 0.1%, in the treatment of psoriasis."
01/01/1976 - "Hydrocortisone 17-butyrate is a new non-fluorinated topical corticosteroid for use in psoriasis, eczema and other inflammatory dermatoses. "
01/01/1980 - "A double-blind, randomized trial was carried out in 60 patients with varicose (hypostatic) eczema to compare the efficacy and tolerance of treatment with 0.25% desoxymethasone in an oily cream base, the oily cream base alone, and 0.1% hydrocortisone 17-butyrate cream. "
01/01/1980 - "A randomized, double-blind therapeutic trial of 0.25% desoxymethasone and 0.1% hydrocortisone 17-butyrate in the treatment of varicose eczema."
02/01/1996 - "This is a randomized, double-blind, parallel-group, multicenter study involving 120 patients comparing the safety and tolerability of two midpotency topical preparations, fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of moderate-to-severe eczema. "
02/01/1996 - "Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema."
01/01/1980 - "Children with extensive eczema received either 60 g of hydrocortisone 17-butyrate or 60 g of hydrocortisone weekly for 4 weeks. "
06/01/2011 - "Hydrocortisone-17-butyrate allergy was associated with duration of disease in both crude and adjusted analyses. "
02/01/1992 - "Incidence of allergic reactions to hydrocortisone-17-butyrate in standard patch test series."
12/01/1980 - "Allergy to hydrocortisone-17-butyrate."
12/01/1979 - "Contact allergy to hydrocortisone 17-butyrate."
07/01/1979 - "Contact allergy to hydrocortisone-17-butyrate."
|2.||Betamethasone 17-Valerate (Betamethasone 17 Valerate)
|4.||Adrenal Cortex Hormones (Corticosteroids)
|6.||Fusidic Acid (Fucithalmic)
|8.||Triamcinolone Acetonide (Azmacort)
|9.||Fluocinolone Acetonide (Capex)
|2.||Phototherapy (Light Therapy)